ArticleApplied microbiology and biotechnology2020
Engineering an oleaginous yeast Candida tropicalis SY005 for enhanced lipid production.
Article in Applied microbiology and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 12 citations in OpenAlex.
- Genomic features, metabolism, and biotechnological applications of Candida tropicalis and other non-albicans Candida species.World journal of microbiology & biotechnology · 2026Review
- Rice Big Grain1 enhances biomass and plant growth-promoting traits in rhizospheric yeast Candida tropicalis.Applied microbiology and biotechnology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Candida tropicalis has recently emerged as a valuable yeast species with respect to lipid metabolism, not only for its oleaginous characteristics but also for its ability to utilize diverse range of substrates. Hence, it can be explored as an ideal host for lipid metabolic engineering, although inadequate genetic transformation system for developing the stable transformant has limited this scope. To resolve this existing constraint, we have come up with a novel strategy of a genomic integrating system in the oleaginous strain SY005 of C. tropicalis. Employing this system, comprising of host-specific regulatable promoter, transcription terminator, and integration locus, we have first examined the expression of a reporter gene, and then ectopically expressed a transcription factor CtRAP1 encoding the repressor activator protein 1 of C. tropicalis SY005. A maximum lipid content of 0.37 g/g dry cell weight was achieved in the engineered strain upon galactose induction, leading to 60% (w/w) increase relative to the wild type strain SY005. This work demonstrates the use of a markerless integrative transformation system to promote lipid accumulation in the diploid yeast without applying nutrient stress and hampering cell growth. The findings of this study will augment the research on lipid metabolic engineering and exploit the enormous potential of C. tropicalis as an industrial lipid feedstock. Key points •A transformation system was established in oleaginous yeast Candida tropicalis SY005 •Activity of host-specific molecular elements was verified by reporter gene expression •SY005 was engineered to ectopically express a transcriptional regulator gene CtRAP1 •The engineered strain exhibited 60% increase in lipid content on galactose induction •The increase in lipid content was correlated with the induced expression of CtRAP1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.